BIOFRONTERA AG Business Summary
Number of employees: 97
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceuticals and Medical Products
100.0
%
| 26 | 100.0 % | 32 | 100.0 % | +25.30% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
68.9
%
| 17 | 66.6 % | 22 | 68.9 % | +29.70% |
Germany
19.4
%
| 5 | 18.5 % | 6 | 19.4 % | +31.37% |
Spain
5.4
%
| - | - | 2 | 5.4 % | - |
Other European Countries
3.7
%
| - | - | 1 | 3.7 % | - |
United Kingdom
2.2
%
| - | - | 1 | 2.2 % | - |
Other Regions
0.3
%
| 0 | 1.3 % | 0 | 0.3 % | -69.01% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 46 | 21-12-13 |
Helge Lubenow
CHM | Chairman | 56 | 21-12-13 |
| Director/Board Member | 65 | 22-08-22 | |
Jörgen Tielmann
BRD | Director/Board Member | - | 21-12-13 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 6,076,862 | 4,344,669 ( 71.50 %) | 0 | 71.50 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
BIOFRONTERA INC. 7.86% | 400,000 | 7.86% | 359,200 $ |
Company contact information
Sector
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| +62.66% | 854B | |
| +40.42% | 636B | |
| -4.37% | 361B | |
| +17.16% | 324B | |
| +9.87% | 301B | |
| +15.66% | 247B | |
| +4.21% | 230B | |
| +17.90% | 228B | |
| +14.86% | 177B |
